KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Restructuring Costs (2016 - 2025)

Labcorp Holdings' Restructuring Costs history spans 17 years, with the latest figure at $5.9 million for Q3 2025.

  • For Q3 2025, Restructuring Costs fell 67.22% year-over-year to $5.9 million; the TTM value through Sep 2025 reached $27.8 million, down 47.45%, while the annual FY2024 figure was $46.0 million, 6.31% down from the prior year.
  • Restructuring Costs for Q3 2025 was $5.9 million at Labcorp Holdings, up from $4.1 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $31.5 million in Q2 2022 and bottomed at -$11.3 million in Q4 2021.
  • The 5-year median for Restructuring Costs is $9.0 million (2022), against an average of $10.0 million.
  • The largest annual shift saw Restructuring Costs tumbled 764.71% in 2021 before it surged 733.33% in 2023.
  • A 5-year view of Restructuring Costs shows it stood at -$11.3 million in 2021, then soared by 179.65% to $9.0 million in 2022, then skyrocketed by 103.33% to $18.3 million in 2023, then tumbled by 37.7% to $11.4 million in 2024, then tumbled by 48.25% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Restructuring Costs are $5.9 million (Q3 2025), $4.1 million (Q2 2025), and $6.4 million (Q1 2025).